Remove 2006 Remove Labelling Remove Vaccines
article thumbnail

Top 20 Radiopharma Companies Based on Market Cap

PharmaShots

FAP-2286 (labeled with lutetium-177), a peptide-targeted radionuclide therapy (PTRT) and imaging agent targeting fibroblast activation protein (FAP), is the company’s lead asset amongst radiopharma products. In 2021, Telix generated total revenue of $7.59M from the sales of its radiopharma products.

Dosage 56
article thumbnail

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2003-2022)

PharmaShots

by the sales of Humira 2006 Johnson & Johnson recorded global sales of $53.3B in the year 2006, thereby depicting a growth rate of 5.6%. in revenue following the addition of Pfizer’s consumer health business in the year 2006. in revenue following the addition of Pfizer’s consumer health business in the year 2006.

article thumbnail

A history of Johnson & Johnson

pharmaphorum

Robert Wood’s granddaughter, Mary Lea, was the first baby to be used on the baby powder label. In 2006, J&J acquired Pfizer Consumer Healthcare for $16.6 Johnson’s Baby Powder also went on sale during this year and was extremely successful. billion in cash.

Vaccines 126